CO2018012905A2 - Vacuna contra la bronquitis infecciosa - Google Patents
Vacuna contra la bronquitis infecciosaInfo
- Publication number
- CO2018012905A2 CO2018012905A2 CONC2018/0012905A CO2018012905A CO2018012905A2 CO 2018012905 A2 CO2018012905 A2 CO 2018012905A2 CO 2018012905 A CO2018012905 A CO 2018012905A CO 2018012905 A2 CO2018012905 A2 CO 2018012905A2
- Authority
- CO
- Colombia
- Prior art keywords
- infectious bronchitis
- bronchitis vaccine
- vaccine
- vaccines
- adjuvated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Se proporcionan vacunas de aves de corral contra la bronquitis infecciosa y rinotraqueitis del pavo. Las vacunas están adyuvadas con una emulsión acuosa que contiene un oligonucleótido inmunoestimulante. También se proporcionan los métodos de uso de las vacunas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662344598P | 2016-06-02 | 2016-06-02 | |
US201662365419P | 2016-07-22 | 2016-07-22 | |
PCT/US2017/035105 WO2017210244A1 (en) | 2016-06-02 | 2017-05-31 | Vaccine against infectious bronchitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2018012905A2 true CO2018012905A2 (es) | 2018-12-14 |
Family
ID=59215993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2018/0012905A CO2018012905A2 (es) | 2016-06-02 | 2018-11-28 | Vacuna contra la bronquitis infecciosa |
Country Status (16)
Country | Link |
---|---|
US (2) | US11103573B2 (es) |
EP (1) | EP3463446A1 (es) |
JP (2) | JP2019517526A (es) |
KR (5) | KR20180129926A (es) |
CN (1) | CN109152829A (es) |
AU (1) | AU2017274332A1 (es) |
BR (1) | BR112018075033A2 (es) |
CA (2) | CA3175832A1 (es) |
CL (2) | CL2018003420A1 (es) |
CO (1) | CO2018012905A2 (es) |
MX (3) | MX2018014857A (es) |
PH (1) | PH12018502525A1 (es) |
RU (1) | RU2021117820A (es) |
UA (1) | UA126562C2 (es) |
WO (1) | WO2017210244A1 (es) |
ZA (3) | ZA201807477B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111303252A (zh) * | 2020-02-17 | 2020-06-19 | 青岛易邦生物工程有限公司 | 一种规模化生产胚毒类抗原的净化方法 |
WO2024077025A1 (en) * | 2022-10-04 | 2024-04-11 | Zoetis Services Llc | Poultry vaccines and methods of protecting poultry |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA978434B (en) * | 1996-09-27 | 1998-03-26 | Akzo Nobel Nv | Inactivated vaccines. |
CA2238659C (en) * | 1997-05-26 | 2010-12-14 | Akzo Nobel N.V. | Recombinant birnavirus vaccine |
US6048535A (en) | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
US8088388B2 (en) | 2002-02-14 | 2012-01-03 | United Biomedical, Inc. | Stabilized synthetic immunogen delivery system |
KR101172921B1 (ko) | 2004-03-12 | 2012-08-13 | 와이어쓰 엘엘씨 | 감염성 점액낭병 바이러스 항원 분리체 및 백신 |
GB0428394D0 (en) * | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
CN101517082B (zh) | 2006-09-27 | 2014-01-22 | 科勒制药有限责任公司 | 具有增强的免疫刺激活性的含疏水性T类似物的CpG寡聚核苷酸类似物 |
DK2310046T3 (da) | 2008-06-27 | 2016-04-25 | Zoetis Services Llc | Hidtil ukendte adjuvanssammensætninger |
AR072976A1 (es) * | 2008-08-08 | 2010-10-06 | Wyeth Corp | Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo |
CN101721698B (zh) | 2008-10-24 | 2014-04-02 | 法罗斯疫苗公司 | 抗口蹄疫疫苗组合物及其制备和应用 |
PL2376107T3 (pl) * | 2008-12-09 | 2014-09-30 | Coley Pharm Group Inc | Oligonukleotydy immunostymulujące |
CN102038949A (zh) * | 2010-12-29 | 2011-05-04 | 青岛易邦生物工程有限公司 | 鸡新城疫、传染性支气管炎、减蛋综合征、禽流感(h9亚型)四联灭活疫苗的生产方法 |
EP2471926A3 (en) * | 2010-12-30 | 2012-07-11 | Intervet International BV | Immunostimulatory oligodeoxynucleotides |
CN104244973B (zh) | 2012-11-16 | 2017-10-20 | 美国联合生物医学公司 | 针对口蹄疫(fmd)的基于合成肽的紧急疫苗 |
CA3005608C (en) | 2013-09-19 | 2020-06-30 | Zoetis Services Llc | Water-in-oil emulsions comprising immunostimulatory oligonucleotides |
-
2017
- 2017-05-31 UA UAA201811848A patent/UA126562C2/uk unknown
- 2017-05-31 MX MX2018014857A patent/MX2018014857A/es unknown
- 2017-05-31 KR KR1020187032533A patent/KR20180129926A/ko active Application Filing
- 2017-05-31 WO PCT/US2017/035105 patent/WO2017210244A1/en unknown
- 2017-05-31 KR KR1020227022129A patent/KR20220100725A/ko not_active Application Discontinuation
- 2017-05-31 KR KR1020217016601A patent/KR20210068602A/ko not_active Application Discontinuation
- 2017-05-31 CN CN201780029740.XA patent/CN109152829A/zh active Pending
- 2017-05-31 KR KR1020217016599A patent/KR20210068601A/ko not_active Application Discontinuation
- 2017-05-31 CA CA3175832A patent/CA3175832A1/en active Pending
- 2017-05-31 BR BR112018075033-6A patent/BR112018075033A2/pt unknown
- 2017-05-31 JP JP2018563490A patent/JP2019517526A/ja active Pending
- 2017-05-31 AU AU2017274332A patent/AU2017274332A1/en active Pending
- 2017-05-31 RU RU2021117820A patent/RU2021117820A/ru unknown
- 2017-05-31 EP EP17733220.2A patent/EP3463446A1/en active Pending
- 2017-05-31 CA CA3025524A patent/CA3025524C/en active Active
- 2017-05-31 US US16/309,216 patent/US11103573B2/en active Active
- 2017-05-31 KR KR1020227015039A patent/KR20220064417A/ko not_active Application Discontinuation
-
2018
- 2018-11-07 ZA ZA2018/07477A patent/ZA201807477B/en unknown
- 2018-11-28 CO CONC2018/0012905A patent/CO2018012905A2/es unknown
- 2018-11-29 PH PH12018502525A patent/PH12018502525A1/en unknown
- 2018-11-30 CL CL2018003420A patent/CL2018003420A1/es unknown
- 2018-11-30 MX MX2022007212A patent/MX2022007212A/es unknown
- 2018-11-30 MX MX2022012910A patent/MX2022012910A/es unknown
-
2020
- 2020-11-06 CL CL2020002876A patent/CL2020002876A1/es unknown
-
2021
- 2021-07-13 US US17/374,399 patent/US20220175911A1/en active Pending
-
2022
- 2022-05-06 ZA ZA2022/04980A patent/ZA202204980B/en unknown
- 2022-05-06 ZA ZA2022/04979A patent/ZA202204979B/en unknown
- 2022-09-26 JP JP2022152642A patent/JP2023002541A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3463446A1 (en) | 2019-04-10 |
JP2023002541A (ja) | 2023-01-10 |
KR20220064417A (ko) | 2022-05-18 |
RU2018142329A3 (es) | 2020-09-01 |
CL2018003420A1 (es) | 2019-01-18 |
US20190240315A1 (en) | 2019-08-08 |
KR20180129926A (ko) | 2018-12-05 |
KR20220100725A (ko) | 2022-07-15 |
US11103573B2 (en) | 2021-08-31 |
CA3175832A1 (en) | 2017-12-07 |
KR20210068601A (ko) | 2021-06-09 |
PH12018502525A1 (en) | 2019-10-21 |
KR20210068602A (ko) | 2021-06-09 |
CN109152829A (zh) | 2019-01-04 |
ZA202204979B (en) | 2022-09-28 |
ZA201807477B (en) | 2023-06-28 |
JP2019517526A (ja) | 2019-06-24 |
US20220175911A1 (en) | 2022-06-09 |
CA3025524C (en) | 2023-03-07 |
UA126562C2 (uk) | 2022-11-02 |
CL2020002876A1 (es) | 2021-05-07 |
CA3025524A1 (en) | 2017-12-07 |
MX2022012910A (es) | 2022-11-14 |
BR112018075033A2 (pt) | 2019-03-26 |
ZA202204980B (en) | 2022-09-28 |
RU2018142329A (ru) | 2020-06-01 |
RU2021117820A (ru) | 2021-07-07 |
WO2017210244A1 (en) | 2017-12-07 |
MX2022007212A (es) | 2022-07-12 |
AU2017274332A1 (en) | 2018-11-22 |
MX2018014857A (es) | 2019-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019001640A1 (es) | Vectores recombinantes de hvt que expresan múltiples antígenos de patógenos de aves y sus usos. | |
CL2018001056A1 (es) | Vacuna contra el virus herpes simplex | |
CL2018001051A1 (es) | Vacunas de ácido nucleico contra el virus varicela zoster (vzv) | |
MX2020004367A (es) | Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan. | |
PE20190397A1 (es) | Virus de enteritis de pato y usos del mismo | |
CO2018012905A2 (es) | Vacuna contra la bronquitis infecciosa | |
CY1118704T1 (el) | Ανθρωπινος πληθυσμος βλαστοκυτταρων του τραχηλου της μητρας και χρησεις αυτου | |
BR112017003462A2 (pt) | coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino. | |
CL2016001912A1 (es) | Vacunas comestibles en base a algas | |
NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
AR090450A1 (es) | Vacuna de herpesvirus-1 equino recombinante que contiene glicoproteina c mutada y usos de la misma | |
AR115069A1 (es) | Virus vacuna quimérico sintético | |
MX2018008529A (es) | Virus de la tilapia de tipo ortomixo. | |
AR089995A1 (es) | Vacunas de subunidades de rotavirus, metodos de preparacion y uso de las mismas | |
BR112016001686A2 (pt) | Vacina, método para a preparação de uma vacina, composição, e, uso de uma composição | |
CL2016001906A1 (es) | Vacunas contra el reovirus aviar. | |
AR106559A1 (es) | Suspensión acuosa para administración oral y método para su preparación | |
UY36208A (es) | “bacterias modificadas para vacunas mejoradas contra la brucelosis”. | |
BR112017011881A2 (pt) | microvesículas cheias com gás para uso como vacina | |
AR125960A2 (es) | Vacuna para uso en aves de corral contra la bursitis infecciosa | |
AR089868A1 (es) | Vacuna vectorial de eimeria para campylobacter jejuni | |
AR105539A1 (es) | Potenciamiento de la respuesta inmunológica en especies acuáticas | |
AR108664A1 (es) | Vacuna contra la bronquitis infecciosa | |
AR101124A1 (es) | Bacterias modificadas para vacunas mejoradas contra la brucelosis | |
MX2020006327A (es) | Deteccion de vacunas vivas modificadas contra el virus de la gripe porcina. |